Scleroderma Pragmatic Trials
Funding Need: $46,500
Scleroderma is an autoimmune, rheumatic and chronic disease that affects the body by hardening its connective tissue. In scleroderma, cells start making collagen as if there were an injury that needs repairing. The cells do not turn off and produce too much collagen. This can prevent the body’s organs from functioning normally. This disease, which has no cure and can be life-threatening, affects 40,000 Canadians between the ages of 25-55 (more prevalent in women).
Because people with scleroderma present different health issues arising from this chronic disease, Dr. Janet Pope, a medical researcher with Lawson Health Research Institute, is creating a standardized pathway for treatment while developing best practices. These studies will enhance care for the hundreds of scleroderma patients seen in the rheumatology clinic at St. Joseph’s each year.